Wacker adds half-life boosting tech to biologics offering
Wacker Biotech has added a low cost PEGytlation alternative to its biopharmaceutical manufacturing offering in a deal with developer XL-protein.
Archives for November 5, 2012
Novartis to build biotech facility in Singapore
Novartis will spend $500m on a new cell-culture based manufacturing facility in Singapore.
Contracts for Cytovance, Patheon and Angel Biotechnology
New contracts for Cytovance, Patheon and Angel Biotechnology in Outsourcing-pharma.com’s roundup of the latest manufacturing deals.
Merck Millipore and Sistemic to use miRNA for cell culture QC
Merck Millipore and microRNA detection firm Sistemic have teamed up to develop QC kits for stem cell production.